| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus epidermidis (coagulase-negative) |
0.125 |
0.5 |
≤0.06 － 0.5 |
Tigecycline (GAR-936, Tigacyl)  |
497 |
| Staphylococcus epidermidis (coagulase-negative) |
0.25 |
0.5 |
0.125 － 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
497 |
| Staphylococcus epidermidis (coagulase-negative) |
0.25 |
8 |
≤0.06 － 128 |
Levofloxacin (Levaquin, Quixin) |
497 |
| Staphylococcus epidermidis (coagulase-negative) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
497 |
| Staphylococcus epidermidis (coagulase-negative) |
1 |
4 |
0.25 － 8 |
Teicoplanin (Targocid) |
497 |
| Staphylococcus epidermidis (constitutively MLSB) |
>128 |
>128 |
>128 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
15 |
| Staphylococcus epidermidis (constitutively MLSB) |
>128 |
>128 |
>128 － ? |
Cethromycin (ABT-773) |
15 |
| Staphylococcus epidermidis (constitutively MLSB) |
>128 |
>128 |
>128 － ? |
Clarithromycin (Biaxin) |
15 |
| Staphylococcus epidermidis (constitutively MLSB) |
>128 |
>128 |
>128 － ? |
Clindamycin (Cleocin) |
15 |
| Staphylococcus epidermidis (CPHL A2) |
- |
- |
0.06 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
434 |
| Staphylococcus epidermidis (Europe) |
- |
0.5 |
? － ? |
Imipenem |
284 |
| Staphylococcus epidermidis (Europe) |
- |
4 |
? － ? |
Meropenem (Merrem) |
284 |
| Staphylococcus epidermidis (Europe) |
- |
8 |
? － ? |
Cefotaxime (Cephotaxime, Claforan) |
284 |
| Staphylococcus epidermidis (Europe) |
- |
8 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
284 |
| Staphylococcus epidermidis (Europe) |
>- |
>32 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
284 |
| Staphylococcus epidermidis (Europe) |
- |
32 |
? － ? |
Zosyn |
284 |
| Staphylococcus epidermidis (Europe) |
- |
64 |
? － ? |
Piperacillin (Pipracil) |
284 |
| Staphylococcus epidermidis (glycopeptide-intermediate-susceptible) |
- |
- |
0.5 － 1 |
Daptomycin (Cubicin) |
1261 |
| Staphylococcus epidermidis (glycopeptide-intermediate-susceptible) |
- |
- |
8 － ? |
Vancomycin (Vancocyn, Lyphocin) |
1261 |
| Staphylococcus epidermidis (HCF Berset C) |
- |
- |
0.06 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
434 |
| Staphylococcus epidermidis (HE-5) |
- |
- |
31.25 － ? |
Cefepime (Maxipime) |
367 |
| Staphylococcus epidermidis (IFO 3762) |
- |
- |
4 － ? |
Metronidazole (Flagyl) |
105 |
| Staphylococcus epidermidis (IFO 3762) |
- |
- |
6.25 － ? |
FNQ13 |
257 |
| Staphylococcus epidermidis (IFO 3762) |
- |
- |
>250 － ? |
Apigenin |
138 |
| Staphylococcus epidermidis (IFO 3762) |
- |
- |
>250 － ? |
Luteolin |
138 |
| Staphylococcus epidermidis (lab strain) |
- |
- |
100 － ? |
Holarrhena pubescens bark (Neutral fraction) |
384 |
| Staphylococcus epidermidis (linezolid-resistant) |
1 |
2 |
≤0.12 － 4 |
Daptomycin (Cubicin) |
483 |
| Staphylococcus epidermidis (linezolid-resistant) |
4 |
8 |
2 － >64 |
TR-700 |
192 |